VVOS Vivos Therapeutics, Inc. Stock Quote

VVOS [NASD]

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	21.63%	Shs Outstand	23.03M	Perf Week	-5.23%
Market Cap	33.60M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	0.00%	Shs Float	18.04M	Perf Month	-16.67%
Income	-20.30M	PEG	-	EPS next Q	-0.26	Inst Own	10.30%	Short Float	1.51%	Perf Quarter	-50.51%
Sales	16.90M	P/S	1.99	EPS this Y	-44.30%	Inst Trans	10.67%	Short Ratio	2.98	Perf Half Y	-45.49%
Book/sh	1.11	P/B	1.31	EPS next Y	25.80%	ROA	-53.60%	Target Price	4.50	Perf Year	-72.38%
Cash/sh	1.04	P/C	1.40	EPS next 5Y	-	ROE	-70.40%	52W Range	1.18 - 7.09	Perf YTD	-35.56%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-75.20%	52W High	-79.83%	Beta	-
Dividend %	-	Quick Ratio	3.60	Sales past 5Y	-	Gross Margin	74.60%	52W Low	21.19%	ATR	0.21
Employees	158	Current Ratio	3.60	Sales Q/Q	33.30%	Oper. Margin	-	RSI (14)	40.57	Volatility	12.68% 15.49%
Optionable	Yes	Debt/Eq	0.06	EPS Q/Q	-2.00%	Profit Margin	-	Rel Volume	0.05	Prev Close	1.45
Shortable	Yes	LT Debt/Eq	0.01	Earnings	May 16 AMC	Payout	-	Avg Volume	91.49K	Price	1.43
Recom	2.00	SMA20	-12.22%	SMA50	-27.58%	SMA200	-52.20%	Volume	3,664	Change	-1.38%

May-21-22 08:35AM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analysts Just Slashed This Year's Estimates Simply Wall St.
May-16-22 04:05PM	Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update GlobeNewswire
Apr-28-22 07:30AM	Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call GlobeNewswire
Apr-26-22 08:26AM	Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method GlobeNewswire
Mar-31-22 04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update GlobeNewswire
08:14AM	Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call GlobeNewswire
Mar-08-22 09:11AM	Fast Company Selects Vivos Therapeutics for 2022 Worlds Most Innovative Companies List GlobeNewswire -10.75%
Mar-03-22 08:00AM	Vivos Therapeutics Rebrands Proprietary Clinical Protocol for Treating Patients with Breathing and Sleep Disorders GlobeNewswire -7.44%
Mar-02-22 08:00AM	Vivos Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-24-22 08:00AM	Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome GlobeNewswire +8.87%
Jan-27-22 07:30AM	Vivos Therapeutics Files for US Patent on Proprietary New Clinical Protocols After Seeing Further Significant Improvement in Reduction of Key Sleep Apnea Metric GlobeNewswire
Jan-19-22 01:27PM	Hot Penny Stocks: Whats Moving VVOS, GMDA and SBEV Higher Today? InvestorPlace +41.10%
11:44AM	Why Are Vivos Therapeutics Shares Surging Today? Benzinga
07:30AM	Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology GlobeNewswire
Dec-14-21 01:11PM	Amidst increasing losses, Investors bid up Vivos Therapeutics (NASDAQ:VVOS) 19% this past week Simply Wall St. -7.01%
07:30AM	Vivos Therapeutics mmRNA Oral Appliance Now Eligible for Medicare Reimbursement GlobeNewswire
Dec-09-21 07:30AM	Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep Disorder, Snoring and Sleep Apnea Appliances to Canadian Dentists GlobeNewswire
Dec-03-21 07:30AM	Vivos Therapeutics to Participate at the Benzinga Global Small Cap Conference GlobeNewswire -8.03%
Nov-15-21 04:05PM	Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update GlobeNewswire
07:00AM	Vivos Therapeutics to Participate at the Q4 Virtual Investor Summit GlobeNewswire
Nov-09-21 07:30AM	Vivos Therapeutics Schedules Third Quarter 2021 Financial Results Conference Call GlobeNewswire
Oct-22-21 07:30AM	Vivos Therapeutics to Participate at the Benzinga Global Small Cap Conference GlobeNewswire
Oct-20-21 11:17AM	Vivos Therapeutics Inc., Candid to Bring Airway and Sleep, Oral Health, Orthodontic Therapy Together in Comprehensive Solution Benzinga
Oct-19-21 04:00PM	Vivos Therapeutics Announces 2021 Annual Breathing Wellness Conference Presented by The Vivos Institute GlobeNewswire
11:30AM	Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution PR Newswire
Oct-18-21 07:30AM	Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution GlobeNewswire +9.30%
Oct-13-21 10:59AM	Vivos Therapeutics Inc.'s Guides Demonstrate Significant Reduction of Pediatric Tooth Decay in Peer-Reviewed Study Benzinga
07:30AM	Children in Latest Clinical Study Show Significant Reduction of Tooth Decay After Treatment with Vivos Guides GlobeNewswire
Sep-29-21 07:03AM	16 Stocks Moving in Wednesday's Pre-Market Session Benzinga -6.09%
Sep-23-21 12:28PM	Vivos Therapeutics Inc. Forms Medical Consortium To Advance OSA Technology Benzinga
07:30AM	Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Companys Technology for Obstructive Sleep Apnea GlobeNewswire
Sep-22-21 11:01AM	Vivos Therapeutics Inc. To Present At Benzinga Healthcare Small Cap Conference Benzinga
07:30AM	Vivos Therapeutics to Participate at the Benzinga Healthcare Small Cap Conference GlobeNewswire
Sep-08-21 07:30AM	Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire -6.22%
Aug-26-21 09:08AM	Implied Volatility Surging for Vivos (VVOS) Stock Options Zacks
07:30AM	Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment GlobeNewswire
Aug-24-21 10:13AM	Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates Benzinga -7.29%
Aug-23-21 02:44PM	Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher Benzinga +53.65%
11:17AM	BioMedNewsBreaks Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance Benzinga
09:27AM	Why Vivos Therapeutics Shares Are Soaring Today Benzinga
08:36AM	Top 5 Stock Gainers for Monday: Pfizer, Trillium, NextGen, Vivos TheStreet.com
07:57AM	Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device Benzinga
07:30AM	FDA Grants 510(k) Market Clearance to Vivos Therapeutics mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea GlobeNewswire
07:15AM	Vivos Therapeutics Stock Leaps as FDA Clears Sleep-Apnea Device TheStreet.com
Aug-17-21 04:05PM	Detailed Summary of Study Reporting that One in Four Patients Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment Now Available on Vivos Therapeutics Website GlobeNewswire +16.84%
Aug-12-21 04:05PM	Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update GlobeNewswire
Aug-09-21 04:05PM	Vivos Therapeutics to Participate at the Q3 Virtual Investor Summit GlobeNewswire
08:00AM	Vivos Therapeutics Schedules Second Quarter 2021 Financial Results Conference Call GlobeNewswire
Jul-29-21 08:00AM	Vivos Therapeutics Opens State of the Art International Training Center In Denver GlobeNewswire
Jul-13-21 08:00AM	One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment GlobeNewswire
Jul-07-21 08:00AM	Independent Study Shows 97 Percent of Vivos Patients Achieved Their Desired Treatment Outcome GlobeNewswire +23.52%
Jun-15-21 06:41AM	Is Vivos Therapeutics, Inc. (VVOS) A Good Stock To Buy? Insider Monkey
May-26-21 08:00AM	Vivos Therapeutics Founder & Chief Medical Officer Releases New Book Highlighting His Groundbreaking Work GlobeNewswire +5.71%
May-17-21 04:05PM	Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update GlobeNewswire
03:15PM	Vivos Therapeutics Inc to Host Earnings Call ACCESSWIRE
May-14-21 07:27AM	What Type Of Shareholders Own The Most Number of Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares? Simply Wall St.
May-13-21 08:00AM	Vivos Therapeutics Schedules First Quarter 2021 Financial Results Conference Call GlobeNewswire
May-11-21 04:29PM	Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares GlobeNewswire
May-06-21 09:41PM	Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering GlobeNewswire
Apr-15-21 10:54AM	Vivos Therapeutics Leads the Battle Against Obstructive Sleep Apnea (OSA) Benzinga
Apr-14-21 09:15AM	Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education GlobeNewswire
Apr-12-21 08:00AM	Vivos Therapeutics to Participate at the Emerging Growth Conference GlobeNewswire
06:00AM	CEO Presenting on the Emerging Growth Conference on April 14; Register now GlobeNewswire
Apr-09-21 06:16AM	Investing in Sleep Apnea Companies Motley Fool
Mar-30-21 08:00AM	Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service GlobeNewswire
Mar-25-21 04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update GlobeNewswire
03:15PM	Vivos Therapeutics Inc to Host Earnings Call ACCESSWIRE
Mar-22-21 04:05PM	Vivos Therapeutics to Participate at the Benzinga Biotech Small Cap Conference GlobeNewswire
Mar-18-21 08:00AM	Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5:00 pm ET GlobeNewswire
Mar-11-21 07:55AM	Vivos Therapeutics to Participate at the Q1 Virtual Investor Summit GlobeNewswire
Mar-08-21 08:00AM	Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center GlobeNewswire
Mar-01-21 08:00AM	Vivos Therapeutics to Participate in the Virtual 33rd Annual ROTH Conference on March 15-17, 2021 GlobeNewswire
Feb-16-21 08:00AM	Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults GlobeNewswire +11.55%
Feb-02-21 08:00AM	Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance GlobeNewswire
Jan-29-21 08:00AM	Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts GlobeNewswire
Jan-06-21 08:00AM	Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea GlobeNewswire
Dec-28-20 11:26AM	Insider Buys Vivos Therapeutics Shares Benzinga -5.28%
Dec-17-20 12:23PM	Biotech Pair Halted After IPO Craze Triggers Massive Rallies Bloomberg +34.37%
Dec-15-20 05:18PM	Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares GlobeNewswire -8.60%
Dec-11-20 05:39PM	Certara IPO Soars 66%. Employees Will Get Shares. Barrons.com
05:25PM	AbCellera Rockets 195%, 4D Molecular Up 76% as Flurry of Health-Care IPOs Begin Trading Barrons.com
05:23PM	Vivos Stock Soars as Much as 140% in IPO Barrons.com

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Huntsman Ronald Kirk	Chief Executive Officer	Sep 21	Buy	4.31	5,000	21,550	15,500	Sep 22 03:09 PM
Huntsman Ronald Kirk	Chief Executive Officer	Aug 17	Buy	3.00	5,000	15,000	10,500	Aug 18 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience